Machine Learning-Guided Discovery of Natural BACE1 Inhibitors with Enzymatic and Cellular Validation
This research provides new technology and potential lead compound for the development of future anti-Alzheimer’s disease drug as well as demonstrates that integrating machine learning-assisted virtual screening with natural product libraries is an effective strategy for discovering novel BACE1 inhibitors.